Maynard Um
-
-
-
-
-
-
-
Organon (OGN) Tops Q3 EPS by 7c ; Offers Guidance
-
-
-
-
-
-
-
FDA approves Henlius and Organon's denosumab biosimilars BILDYOS and BILPREVDA
-
-
-
-
-
-
-
OGN SECURITIES NOTICE: Investors of Organon & Co. are Alerted to Contact BFA Law before July 22 Class Action Deadline
-
-
-
-
-
-
-
Berger Montague Reminds Organon & Co. (OGN) Investors With Substantial Losses to Inquire About a Securities Fraud Class Action by July 22, 2025
-
-
-
-
-
-
-
OGN FRAUD: Contact BFA Law by July 22 Court Deadline if You Suffered Losses on Your Organon & Co. Investment
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
-
-
-
-
-
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

